Home/Filings/4/0001562180-24-006432
4//SEC Filing

ANDO GORAN 4

Accession 0001562180-24-006432

CIK 0001314102other

Filed

Aug 20, 8:00 PM ET

Accepted

Aug 21, 4:01 PM ET

Size

4.8 KB

Accession

0001562180-24-006432

Insider Transaction Report

Form 4
Period: 2024-08-21
ANDO GORAN
Director
Transactions
  • Purchase

    Common Stock

    2024-08-21$7.95/sh+5,000$39,75013,150 total

Issuer

EyePoint Pharmaceuticals, Inc.

CIK 0001314102

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001110748

Filing Metadata

Form type
4
Filed
Aug 20, 8:00 PM ET
Accepted
Aug 21, 4:01 PM ET
Size
4.8 KB